What does the evidence tell us about the shingles vaccine and dementia?
Researchers say a shingles vaccine could slow the progression of dementia and lower the risk of dying from it. Earlier this year, they produced the strongest evidence yet that the vaccine might reduce the risk of getting dementia in the first place. Dr. Nathan Stall, a clinician scientist and geriatrics lead at Sinai Health explains why shingles may be linked to cognitive decline and how a shingles vaccine could help.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.
The Dose · CBC
Audio is streamed directly from the publisher (mgln.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Researchers say a shingles vaccine could slow the progression of dementia and lower the risk of dying from it. Earlier this year, they produced the strongest evidence yet that the vaccine might reduce the risk of getting dementia in the first place. Dr. Nathan Stall, a clinician scientist and geriatrics lead at Sinai Health explains why shingles may be linked to cognitive decline and how a shingles vaccine could help.
For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.